We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
iShares Russell 1000 Value ETF
IWD
$83.6B
| $13.3M | 0.02% |
84,904
+8,986
| +12% | +$1.44M |
|
802
Intellia Therapeutics
NTLA
$1.66B
| $13.3M | 0.02% |
98,782
+315
| +0.3% | +$47.7K |
|
803
Bread Financial
BFH
$4.39B
| $13.2M | 0.02% |
164,355
-2,166
| -1% | -$167K |
|
804
Upstart Holdings
UPST
$2.98B
| $13.2M | 0.02% |
41,759
+29,155
| +231% | +$5.75M |
|
805
Unum
UNM
$14.2B
| $13.2M | 0.02% |
527,191
+190,691
| +57% | +$5.05M |
|
806
NeoGenomics
NEO
$2.11B
| $13.2M | 0.02% |
273,370
-39,696
| -13% | -$1.84M |
|
807
PVH
PVH
$4.03B
| $13.2M | 0.02% |
128,121
-2,987
| -2% | -$321K |
|
808
Invesco
IVZ
$14B
| $13.2M | 0.02% |
546,149
-38,492
| -7% | -$963K |
|
809
Pinnacle West Capital
PNW
$12.3B
| $13.1M | 0.02% |
181,244
-13,460
| -7% | -$1.07M |
|
810
MSC Industrial Direct
MSM
$6.91B
| $13M | 0.02% |
162,404
-4,763
| -3% | -$404K |
|
811
Saic
SAIC
$5.37B
| $13M | 0.02% |
151,708
-4,463
| -3% | -$382K |
|
812
Wingstop
WING
$3.17B
| $13M | 0.02% |
79,013
-439
| -0.6% | -$74.4K |
|
813
Neogen
NEOG
$2.48B
| $12.9M | 0.02% |
297,527
+3,819
| +1% | +$166K |
|
|
PSB
814
DELISTED
PS Business Parks, Inc.
PSB
| $12.9M | 0.02% |
82,389
+3,205
| +4% | +$495K |
|
815
HF Sinclair
DINO
$14.6B
| $12.9M | 0.02% |
388,838
-13,242
| -3% | -$403K |
|
816
APA Corp
APA
$13.3B
| $12.9M | 0.02% |
600,402
-37,133
| -6% | -$710K |
|
817
Black Hills Corp
BKH
$5.66B
| $12.9M | 0.02% |
204,973
-167
| -0.1% | -$11.4K |
|
818
AMN Healthcare
AMN
$1.38B
| $12.8M | 0.02% |
111,930
-19,261
| -15% | -$2.04M |
|
819
Wintrust Financial
WTFC
$10.7B
| $12.8M | 0.02% |
159,645
-5,386
| -3% | -$398K |
|
820
Hancock Whitney
HWC
$6.24B
| $12.8M | 0.02% |
272,290
+1,099
| +0.4% | +$48.7K |
|
821
Valmont Industries
VMI
$9.58B
| $12.8M | 0.02% |
54,461
-2,644
| -5% | -$629K |
|
822
Flowers Foods
FLO
$1.57B
| $12.8M | 0.02% |
541,457
-13,282
| -2% | -$315K |
|
823
Boston Beer
SAM
$1.93B
| $12.8M | 0.02% |
25,087
-493
| -2% | -$335K |
|
824
Crown Holdings
CCK
$13.1B
| $12.8M | 0.02% |
126,816
-9,119
| -7% | -$957K |
|
825
W.P. Carey
WPC
$16.4B
| $12.8M | 0.02% |
178,604
-10,674
| -6% | -$813K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.